Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €8.95 | - | - |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.34 | €8.37 | 2335.633% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 557.282% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.62 | - | - |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 950.715% |
| Evotec SE | 4 | 1 | 0 | 0 | €9.97 | €21.50 | 115.647% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €40.19 | €56.86 | 41.483% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.73 | €18.30 | 957.572% |
| Immuron | 0 | 1 | 0 | 1 | €2.24 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Medigene AG | 0 | 2 | 0 | 0 | €1.60 | €1.00 | -37.500% |
| Arca Biopharma | 0 | 22 | 0 | 3 | €3.26 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 474.168% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 1 | €1.07 | €2.00 | 86.480% |
| Merck KGaA | 3 | 1 | 0 | 0 | €150.65 | €146.00 | -3.087% |
| Acadia Pharmaceuticals | 23 | 1 | 3 | 1 | €15.62 | €32.59 | 108.678% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.76 | €67.64 | 65.965% |
| Palisade Bio Inc. | 3 | 1 | 2 | 1 | €0.34 | €21.06 | 6072.333% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.17 | €50.00 | 1100.192% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.50 | - | - |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |